{
  "url": "https://www.webmd.com/fatty-liver-disease/cm/mash-treatments-latest-treatments",
  "title": "The Latest in MASH Treatments: What’s on the Horizon",
  "slug": "mash-treatments-latest-treatments",
  "published_date": "2025-09-24",
  "first_letter": "M",
  "author": "Deanna Altomara",
  "medically_reviewed_by": "Melinda  Ratini, MS, DO",
  "read_time": "8 min read",
  "sections": [
    {
      "heading": null,
      "content": [
        "When you have metabolic dysfunction-associated steatohepatitis (MASH), time is of the essence for treatment. Untreated, it can lead to cirrhosis and liver failure.",
        "Medication will be an important part of your treatment plan for MASH (formerly called nonalcoholic steatohepatitis). Right now, there are only two drugs approved by the FDA for MASH: resmetirom and semaglutide.",
        "But there may be more options soon. Doctors are studying whether other drugs can help with MASH. Some of these drugs are already used for other conditions such as obesity or diabetes. Others are brand new.",
        "You’ll need to partner with your doctor to learn which of these drugs may be right for you. Grace Su, MD, FAASLD, President of the American Association for the Study of Liver Diseases, explains, “Each person is different. Not everyone responds to one particular medication, so decisions about which one to use and when should be personalized depending on the person’s medical history and comorbidities (other conditions).”",
        "Here are a few of the latest and upcoming treatments for MASH:"
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "When you have metabolic dysfunction-associated steatohepatitis (MASH), time is of the essence for treatment. Untreated, it can lead to cirrhosis and liver failure.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Medication will be an important part of your treatment plan for MASH (formerly called nonalcoholic steatohepatitis). Right now, there are only two drugs approved by the FDA for MASH: resmetirom and semaglutide.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "But there may be more options soon. Doctors are studying whether other drugs can help with MASH. Some of these drugs are already used for other conditions such as obesity or diabetes. Others are brand new.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "You’ll need to partner with your doctor to learn which of these drugs may be right for you. Grace Su, MD, FAASLD, President of the American Association for the Study of Liver Diseases, explains, “Each person is different. Not everyone responds to one particular medication, so decisions about which one to use and when should be personalized depending on the person’s medical history and comorbidities (other conditions).”",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Here are a few of the latest and upcoming treatments for MASH:",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "Resmetirom (Rezdiffra)",
      "content": [
        "Resmetirom is approved by the FDA for moderate to advanced liver scarring (fibrosis) caused by MASH. It can slow down or reverse that scarring.",
        "Resmetirom tweaks the way your body absorbs a certain thyroid hormone. This change helps keep fat from building up in your liver, which leads to less inflammation and scarring.",
        "Most other MASH treatments are GLP-1 drugs, which means they affect a different type of hormone.",
        "You take an 80-100 mg pill once a day. To see the best results, you also should follow a healthy diet and exercise.",
        "The FDA has approved resmetirom for the treatment of MASH with stages II and III fibrosis. This means your doctor can write you a prescription for it if it’s the right treatment for you.",
        "Doctors gave almost 900 people with moderate to advanced fibrosis either 80 mg or 100 mg of resmetirom or a placebo (an inactive treatment). One year later, the people who took the drug were more likely to have no additional scarring or a reversal of scarring. About 1 in 4 people who took resmetirom saw their scars improve.",
        "If you’re interested in trying resmetirom, talk to your doctor."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "Resmetirom is approved by the FDA for moderate to advanced liver scarring (fibrosis) caused by MASH. It can slow down or reverse that scarring.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Resmetirom tweaks the way your body absorbs a certain thyroid hormone. This change helps keep fat from building up in your liver, which leads to less inflammation and scarring.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Most other MASH treatments are GLP-1 drugs, which means they affect a different type of hormone.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "You take an 80-100 mg pill once a day. To see the best results, you also should follow a healthy diet and exercise.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "The FDA has approved resmetirom for the treatment of MASH with stages II and III fibrosis. This means your doctor can write you a prescription for it if it’s the right treatment for you.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Doctors gave almost 900 people with moderate to advanced fibrosis either 80 mg or 100 mg of resmetirom or a placebo (an inactive treatment). One year later, the people who took the drug were more likely to have no additional scarring or a reversal of scarring. About 1 in 4 people who took resmetirom saw their scars improve.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "If you’re interested in trying resmetirom, talk to your doctor.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": null,
      "content": [
        "When you have metabolic dysfunction-associated steatohepatitis (MASH), time is of the essence for treatment. Untreated, it can lead to cirrhosis and liver failure.",
        "Medication will be an important part of your treatment plan for MASH (formerly called nonalcoholic steatohepatitis). Right now, there are only two drugs approved by the FDA for MASH: resmetirom and semaglutide.",
        "But there may be more options soon. Doctors are studying whether other drugs can help with MASH. Some of these drugs are already used for other conditions such as obesity or diabetes. Others are brand new.",
        "You’ll need to partner with your doctor to learn which of these drugs may be right for you. Grace Su, MD, FAASLD, President of the American Association for the Study of Liver Diseases, explains, “Each person is different. Not everyone responds to one particular medication, so decisions about which one to use and when should be personalized depending on the person’s medical history and comorbidities (other conditions).”",
        "Here are a few of the latest and upcoming treatments for MASH:"
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "When you have metabolic dysfunction-associated steatohepatitis (MASH), time is of the essence for treatment. Untreated, it can lead to cirrhosis and liver failure.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Medication will be an important part of your treatment plan for MASH (formerly called nonalcoholic steatohepatitis). Right now, there are only two drugs approved by the FDA for MASH: resmetirom and semaglutide.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "But there may be more options soon. Doctors are studying whether other drugs can help with MASH. Some of these drugs are already used for other conditions such as obesity or diabetes. Others are brand new.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "You’ll need to partner with your doctor to learn which of these drugs may be right for you. Grace Su, MD, FAASLD, President of the American Association for the Study of Liver Diseases, explains, “Each person is different. Not everyone responds to one particular medication, so decisions about which one to use and when should be personalized depending on the person’s medical history and comorbidities (other conditions).”",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Here are a few of the latest and upcoming treatments for MASH:",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "Resmetirom (Rezdiffra)",
      "content": [
        "Resmetirom is approved by the FDA for moderate to advanced liver scarring (fibrosis) caused by MASH. It can slow down or reverse that scarring.",
        "Resmetirom tweaks the way your body absorbs a certain thyroid hormone. This change helps keep fat from building up in your liver, which leads to less inflammation and scarring.",
        "Most other MASH treatments are GLP-1 drugs, which means they affect a different type of hormone.",
        "You take an 80-100 mg pill once a day. To see the best results, you also should follow a healthy diet and exercise.",
        "The FDA has approved resmetirom for the treatment of MASH with stages II and III fibrosis. This means your doctor can write you a prescription for it if it’s the right treatment for you.",
        "Doctors gave almost 900 people with moderate to advanced fibrosis either 80 mg or 100 mg of resmetirom or a placebo (an inactive treatment). One year later, the people who took the drug were more likely to have no additional scarring or a reversal of scarring. About 1 in 4 people who took resmetirom saw their scars improve.",
        "If you’re interested in trying resmetirom, talk to your doctor."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "Resmetirom is approved by the FDA for moderate to advanced liver scarring (fibrosis) caused by MASH. It can slow down or reverse that scarring.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Resmetirom tweaks the way your body absorbs a certain thyroid hormone. This change helps keep fat from building up in your liver, which leads to less inflammation and scarring.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Most other MASH treatments are GLP-1 drugs, which means they affect a different type of hormone.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "You take an 80-100 mg pill once a day. To see the best results, you also should follow a healthy diet and exercise.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "The FDA has approved resmetirom for the treatment of MASH with stages II and III fibrosis. This means your doctor can write you a prescription for it if it’s the right treatment for you.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Doctors gave almost 900 people with moderate to advanced fibrosis either 80 mg or 100 mg of resmetirom or a placebo (an inactive treatment). One year later, the people who took the drug were more likely to have no additional scarring or a reversal of scarring. About 1 in 4 people who took resmetirom saw their scars improve.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "If you’re interested in trying resmetirom, talk to your doctor.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "Semaglutide (Ozempic, Wegovy)",
      "content": [
        "You may have heard of semaglutide. It’s famous as a weight loss drug. But Wegovy, a brand of injectable semaglutide, has now been improved to treat MASH.",
        "Semaglutide is a GLP-1 agonist. It fights inflammation and prevents the buildup of fat in the liver.",
        "Semaglutide is related to liraglutide and tirzepatide, which are other GLP-1 agonists. But semaglutide (Wegovy) is the only one to be FDA-approved for MASH with moderate to advanced fibrosis.",
        "You take it as a shot you give yourself once a week.",
        "Semaglutide (Wegovy) is currently in a phase III trial. But the results are so promising that the FDA recently approved it to treat MASH.",
        "In the latest study (the first part of the current phase III trial), 800 people with MASH got a weekly shot with semaglutide (Wegovy) or a placebo. After six months, people who got the semaglutide shot were more likely to have seen improvements."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "You may have heard of semaglutide. It’s famous as a weight loss drug. But Wegovy, a brand of injectable semaglutide, has now been improved to treat MASH.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Semaglutide is a GLP-1 agonist. It fights inflammation and prevents the buildup of fat in the liver.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Semaglutide is related to liraglutide and tirzepatide, which are other GLP-1 agonists. But semaglutide (Wegovy) is the only one to be FDA-approved for MASH with moderate to advanced fibrosis.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "You take it as a shot you give yourself once a week.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Semaglutide (Wegovy) is currently in a phase III trial. But the results are so promising that the FDA recently approved it to treat MASH.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "In the latest study (the first part of the current phase III trial), 800 people with MASH got a weekly shot with semaglutide (Wegovy) or a placebo. After six months, people who got the semaglutide shot were more likely to have seen improvements.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "What’s next?",
      "content": [
        "In total, about two-thirds of people on the semaglutide shot saw their MASH get better with no additional scarring. About one-third didn’t see their MASH get better, but they did have improvements in scarring.",
        "The current phase III trial will continue for another four years. This will help doctors see how the drug works over time. Meanwhile, you can ask your doctor if semaglutide (Wegovy) could help with your MASH."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "In total, about two-thirds of people on the semaglutide shot saw their MASH get better with no additional scarring. About one-third didn’t see their MASH get better, but they did have improvements in scarring.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "The current phase III trial will continue for another four years. This will help doctors see how the drug works over time. Meanwhile, you can ask your doctor if semaglutide (Wegovy) could help with your MASH.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "Liraglutide (Victoza, Saxenda)",
      "content": [
        "Liraglutide is a GLP-1 agonist. It’s mainly used to treat type 2 diabetes. It may also help with MASH, although the FDA hasn’t approved it for this purpose. Your doctor may choose to prescribe it off label.",
        "Liraglutide lowers inflammation and prevents the buildup of fat in the liver. It also helps with weight loss and cardiovascular health.",
        "This drug is a GLP-1 agonist, so it’s closely related to other GLP-1 agonists such as semaglutide and tirzepatide."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "Liraglutide is a GLP-1 agonist. It’s mainly used to treat type 2 diabetes. It may also help with MASH, although the FDA hasn’t approved it for this purpose. Your doctor may choose to prescribe it off label.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Liraglutide lowers inflammation and prevents the buildup of fat in the liver. It also helps with weight loss and cardiovascular health.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "This drug is a GLP-1 agonist, so it’s closely related to other GLP-1 agonists such as semaglutide and tirzepatide.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "Semaglutide (Ozempic, Wegovy)",
      "content": [
        "You may have heard of semaglutide. It’s famous as a weight loss drug. But Wegovy, a brand of injectable semaglutide, has now been improved to treat MASH.",
        "Semaglutide is a GLP-1 agonist. It fights inflammation and prevents the buildup of fat in the liver.",
        "Semaglutide is related to liraglutide and tirzepatide, which are other GLP-1 agonists. But semaglutide (Wegovy) is the only one to be FDA-approved for MASH with moderate to advanced fibrosis.",
        "You take it as a shot you give yourself once a week.",
        "Semaglutide (Wegovy) is currently in a phase III trial. But the results are so promising that the FDA recently approved it to treat MASH.",
        "In the latest study (the first part of the current phase III trial), 800 people with MASH got a weekly shot with semaglutide (Wegovy) or a placebo. After six months, people who got the semaglutide shot were more likely to have seen improvements."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "You may have heard of semaglutide. It’s famous as a weight loss drug. But Wegovy, a brand of injectable semaglutide, has now been improved to treat MASH.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Semaglutide is a GLP-1 agonist. It fights inflammation and prevents the buildup of fat in the liver.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Semaglutide is related to liraglutide and tirzepatide, which are other GLP-1 agonists. But semaglutide (Wegovy) is the only one to be FDA-approved for MASH with moderate to advanced fibrosis.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "You take it as a shot you give yourself once a week.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Semaglutide (Wegovy) is currently in a phase III trial. But the results are so promising that the FDA recently approved it to treat MASH.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "In the latest study (the first part of the current phase III trial), 800 people with MASH got a weekly shot with semaglutide (Wegovy) or a placebo. After six months, people who got the semaglutide shot were more likely to have seen improvements.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "What’s next?",
      "content": [
        "In total, about two-thirds of people on the semaglutide shot saw their MASH get better with no additional scarring. About one-third didn’t see their MASH get better, but they did have improvements in scarring.",
        "The current phase III trial will continue for another four years. This will help doctors see how the drug works over time. Meanwhile, you can ask your doctor if semaglutide (Wegovy) could help with your MASH."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "In total, about two-thirds of people on the semaglutide shot saw their MASH get better with no additional scarring. About one-third didn’t see their MASH get better, but they did have improvements in scarring.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "The current phase III trial will continue for another four years. This will help doctors see how the drug works over time. Meanwhile, you can ask your doctor if semaglutide (Wegovy) could help with your MASH.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "Liraglutide (Victoza, Saxenda)",
      "content": [
        "Liraglutide is a GLP-1 agonist. It’s mainly used to treat type 2 diabetes. It may also help with MASH, although the FDA hasn’t approved it for this purpose. Your doctor may choose to prescribe it off label.",
        "Liraglutide lowers inflammation and prevents the buildup of fat in the liver. It also helps with weight loss and cardiovascular health.",
        "This drug is a GLP-1 agonist, so it’s closely related to other GLP-1 agonists such as semaglutide and tirzepatide."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "Liraglutide is a GLP-1 agonist. It’s mainly used to treat type 2 diabetes. It may also help with MASH, although the FDA hasn’t approved it for this purpose. Your doctor may choose to prescribe it off label.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Liraglutide lowers inflammation and prevents the buildup of fat in the liver. It also helps with weight loss and cardiovascular health.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "This drug is a GLP-1 agonist, so it’s closely related to other GLP-1 agonists such as semaglutide and tirzepatide.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "Where is liraglutide in the research pipeline?",
      "content": [
        "You take it as a daily shot in the upper leg, stomach, or upper arm, which you can give yourself.",
        "It has finished a phase II clinical trial. Right now, it’s available for diabetes but isn’t approved for MASH.",
        "Doctors gave 26 people with MASH a daily shot with liraglutide and 26 a shot without it. After four months, the people who had the liraglutide shot were more likely to see their condition improve.",
        "Doctors need to do larger studies to get a better idea of how liraglutide affects MASH."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "You take it as a daily shot in the upper leg, stomach, or upper arm, which you can give yourself.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "It has finished a phase II clinical trial. Right now, it’s available for diabetes but isn’t approved for MASH.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Doctors gave 26 people with MASH a daily shot with liraglutide and 26 a shot without it. After four months, the people who had the liraglutide shot were more likely to see their condition improve.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Doctors need to do larger studies to get a better idea of how liraglutide affects MASH.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "Tirzepatide (Mounjaro, Zepbound)",
      "content": [
        "This is a GLP-1 agonist like liraglutide and semaglutide.",
        "Like other GLP-1 agonists, tirzepatide fights inflammation and keeps fat from building up in the liver.",
        "Tirzepatide is a GLP-1 agonist, so it’s related to liraglutide and semaglutide. But it’s better for weight loss than its cousins."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "This is a GLP-1 agonist like liraglutide and semaglutide.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Like other GLP-1 agonists, tirzepatide fights inflammation and keeps fat from building up in the liver.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Tirzepatide is a GLP-1 agonist, so it’s related to liraglutide and semaglutide. But it’s better for weight loss than its cousins.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "Where is tirzepatide in the research pipeline?",
      "content": [
        "You take it yourself as a weekly shot.",
        "It’s currently in a phase II clinical trial.",
        "For the phase II clinical trial, doctors gave 190 people with MASH a weekly shot with or without tirzepatide. One year later, the people who had the tirzepatide shot were more likely to have improvements. Up to 62% saw their MASH get better with no additional scarring, and half saw their scarring improve with no worsening of MASH.",
        "Planning for the phase III clinical trial is underway. Doctors will be looking for 4,500 people to participate in the study."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "You take it yourself as a weekly shot.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "It’s currently in a phase II clinical trial.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "For the phase II clinical trial, doctors gave 190 people with MASH a weekly shot with or without tirzepatide. One year later, the people who had the tirzepatide shot were more likely to have improvements. Up to 62% saw their MASH get better with no additional scarring, and half saw their scarring improve with no worsening of MASH.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Planning for the phase III clinical trial is underway. Doctors will be looking for 4,500 people to participate in the study.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "FXR Agents",
      "content": [
        "This drug class works by activating a nuclear receptor in the body called the farnesoid X receptor. It’s a group of drugs that includes cilofexor, obeticholic acid, tropifexor, and vonafexor.",
        "Everything that happens in your body is controlled by your genes. Each gene has an “on” and “off” switch. FXR agents work by pressing the “on” button — the farnesoid X receptor — for certain genes that control bile production and the metabolism of blood sugar and blood fats. They also play a role in liver inflammation and scarring. Turning these genes on may help prevent or reverse the scarring and fibrosis seen in MASH."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "This drug class works by activating a nuclear receptor in the body called the farnesoid X receptor. It’s a group of drugs that includes cilofexor, obeticholic acid, tropifexor, and vonafexor.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Everything that happens in your body is controlled by your genes. Each gene has an “on” and “off” switch. FXR agents work by pressing the “on” button — the farnesoid X receptor — for certain genes that control bile production and the metabolism of blood sugar and blood fats. They also play a role in liver inflammation and scarring. Turning these genes on may help prevent or reverse the scarring and fibrosis seen in MASH.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "Where is liraglutide in the research pipeline?",
      "content": [
        "You take it as a daily shot in the upper leg, stomach, or upper arm, which you can give yourself.",
        "It has finished a phase II clinical trial. Right now, it’s available for diabetes but isn’t approved for MASH.",
        "Doctors gave 26 people with MASH a daily shot with liraglutide and 26 a shot without it. After four months, the people who had the liraglutide shot were more likely to see their condition improve.",
        "Doctors need to do larger studies to get a better idea of how liraglutide affects MASH."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "You take it as a daily shot in the upper leg, stomach, or upper arm, which you can give yourself.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "It has finished a phase II clinical trial. Right now, it’s available for diabetes but isn’t approved for MASH.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Doctors gave 26 people with MASH a daily shot with liraglutide and 26 a shot without it. After four months, the people who had the liraglutide shot were more likely to see their condition improve.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Doctors need to do larger studies to get a better idea of how liraglutide affects MASH.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "Tirzepatide (Mounjaro, Zepbound)",
      "content": [
        "This is a GLP-1 agonist like liraglutide and semaglutide.",
        "Like other GLP-1 agonists, tirzepatide fights inflammation and keeps fat from building up in the liver.",
        "Tirzepatide is a GLP-1 agonist, so it’s related to liraglutide and semaglutide. But it’s better for weight loss than its cousins."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "This is a GLP-1 agonist like liraglutide and semaglutide.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Like other GLP-1 agonists, tirzepatide fights inflammation and keeps fat from building up in the liver.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Tirzepatide is a GLP-1 agonist, so it’s related to liraglutide and semaglutide. But it’s better for weight loss than its cousins.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "Where is tirzepatide in the research pipeline?",
      "content": [
        "You take it yourself as a weekly shot.",
        "It’s currently in a phase II clinical trial.",
        "For the phase II clinical trial, doctors gave 190 people with MASH a weekly shot with or without tirzepatide. One year later, the people who had the tirzepatide shot were more likely to have improvements. Up to 62% saw their MASH get better with no additional scarring, and half saw their scarring improve with no worsening of MASH.",
        "Planning for the phase III clinical trial is underway. Doctors will be looking for 4,500 people to participate in the study."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "You take it yourself as a weekly shot.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "It’s currently in a phase II clinical trial.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "For the phase II clinical trial, doctors gave 190 people with MASH a weekly shot with or without tirzepatide. One year later, the people who had the tirzepatide shot were more likely to have improvements. Up to 62% saw their MASH get better with no additional scarring, and half saw their scarring improve with no worsening of MASH.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Planning for the phase III clinical trial is underway. Doctors will be looking for 4,500 people to participate in the study.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "FXR Agents",
      "content": [
        "This drug class works by activating a nuclear receptor in the body called the farnesoid X receptor. It’s a group of drugs that includes cilofexor, obeticholic acid, tropifexor, and vonafexor.",
        "Everything that happens in your body is controlled by your genes. Each gene has an “on” and “off” switch. FXR agents work by pressing the “on” button — the farnesoid X receptor — for certain genes that control bile production and the metabolism of blood sugar and blood fats. They also play a role in liver inflammation and scarring. Turning these genes on may help prevent or reverse the scarring and fibrosis seen in MASH."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "This drug class works by activating a nuclear receptor in the body called the farnesoid X receptor. It’s a group of drugs that includes cilofexor, obeticholic acid, tropifexor, and vonafexor.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Everything that happens in your body is controlled by your genes. Each gene has an “on” and “off” switch. FXR agents work by pressing the “on” button — the farnesoid X receptor — for certain genes that control bile production and the metabolism of blood sugar and blood fats. They also play a role in liver inflammation and scarring. Turning these genes on may help prevent or reverse the scarring and fibrosis seen in MASH.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "Where are FXR agents in the research pipeline?",
      "content": [
        "Most other MASH treatments work by influencing your body’s hormones. FXR agents turn on certain genes instead.",
        "A phase III clinical trial for obeticholic acid, the most promising FXR agent, was ended early. The company had applied for FDA approval and was denied.",
        "Other FXR agents have finished phase II clinical trials.",
        "A summary of studies on obeticholic acid showed that it improved MASH and scarring. But it also raised cholesterol levels and sometimes caused extreme itchiness.",
        "A phase II study found that taking a combination of cilofexor and firsocostat for four months improved MASH and may help with scarring.",
        "Doctors need to study these drugs in more phase III clinical trials."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "Most other MASH treatments work by influencing your body’s hormones. FXR agents turn on certain genes instead.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "A phase III clinical trial for obeticholic acid, the most promising FXR agent, was ended early. The company had applied for FDA approval and was denied.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Other FXR agents have finished phase II clinical trials.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "A summary of studies on obeticholic acid showed that it improved MASH and scarring. But it also raised cholesterol levels and sometimes caused extreme itchiness.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "A phase II study found that taking a combination of cilofexor and firsocostat for four months improved MASH and may help with scarring.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Doctors need to study these drugs in more phase III clinical trials.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "Pioglitazone",
      "content": [
        "Originally a diabetes drug, pioglitazone raises insulin sensitivity. Some studies suggest it might also help with MASH.",
        "It also clears up inflammation and prevents the buildup of fat in the liver."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "Originally a diabetes drug, pioglitazone raises insulin sensitivity. Some studies suggest it might also help with MASH.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "It also clears up inflammation and prevents the buildup of fat in the liver.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "How is pioglitazone taken?",
      "content": [
        "Most other MASH treatments are GLP-1 agonists, but this one is a PPAR-γ agonist. That means it works on a different chemical in the body.",
        "You take 30-45 mg per day as a tablet.",
        "Pioglitazone has been studied in phase III and IV clinical trials, but it hasn’t been approved by the FDA to treat MASH.",
        "The evidence is mixed. In one study, doctors gave 247 people with MASH and without diabetes a daily pill with either pioglitazone, vitamin E, or a placebo. After 22 months, people who took pioglitazone did not have improvements in their MASH.",
        "But other studies have shown the pioglitazone fights MASH and calms down inflammation. It also may help a little bit with liver scarring. It may be especially effective for people with type 2 diabetes.",
        "We need more research to know for sure how effective this medication is. Doctors are looking for people with type 2 diabetes and MASH to participate in a phase II clinical trial ."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "Most other MASH treatments are GLP-1 agonists, but this one is a PPAR-γ agonist. That means it works on a different chemical in the body.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "You take 30-45 mg per day as a tablet.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Pioglitazone has been studied in phase III and IV clinical trials, but it hasn’t been approved by the FDA to treat MASH.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "The evidence is mixed. In one study, doctors gave 247 people with MASH and without diabetes a daily pill with either pioglitazone, vitamin E, or a placebo. After 22 months, people who took pioglitazone did not have improvements in their MASH.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "But other studies have shown the pioglitazone fights MASH and calms down inflammation. It also may help a little bit with liver scarring. It may be especially effective for people with type 2 diabetes.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "We need more research to know for sure how effective this medication is. Doctors are looking for people with type 2 diabetes and MASH to participate in a phase II clinical trial .",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "Where are FXR agents in the research pipeline?",
      "content": [
        "Most other MASH treatments work by influencing your body’s hormones. FXR agents turn on certain genes instead.",
        "A phase III clinical trial for obeticholic acid, the most promising FXR agent, was ended early. The company had applied for FDA approval and was denied.",
        "Other FXR agents have finished phase II clinical trials.",
        "A summary of studies on obeticholic acid showed that it improved MASH and scarring. But it also raised cholesterol levels and sometimes caused extreme itchiness.",
        "A phase II study found that taking a combination of cilofexor and firsocostat for four months improved MASH and may help with scarring.",
        "Doctors need to study these drugs in more phase III clinical trials."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "Most other MASH treatments work by influencing your body’s hormones. FXR agents turn on certain genes instead.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "A phase III clinical trial for obeticholic acid, the most promising FXR agent, was ended early. The company had applied for FDA approval and was denied.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Other FXR agents have finished phase II clinical trials.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "A summary of studies on obeticholic acid showed that it improved MASH and scarring. But it also raised cholesterol levels and sometimes caused extreme itchiness.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "A phase II study found that taking a combination of cilofexor and firsocostat for four months improved MASH and may help with scarring.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Doctors need to study these drugs in more phase III clinical trials.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "Pioglitazone",
      "content": [
        "Originally a diabetes drug, pioglitazone raises insulin sensitivity. Some studies suggest it might also help with MASH.",
        "It also clears up inflammation and prevents the buildup of fat in the liver."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "Originally a diabetes drug, pioglitazone raises insulin sensitivity. Some studies suggest it might also help with MASH.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "It also clears up inflammation and prevents the buildup of fat in the liver.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "How is pioglitazone taken?",
      "content": [
        "Most other MASH treatments are GLP-1 agonists, but this one is a PPAR-γ agonist. That means it works on a different chemical in the body.",
        "You take 30-45 mg per day as a tablet.",
        "Pioglitazone has been studied in phase III and IV clinical trials, but it hasn’t been approved by the FDA to treat MASH.",
        "The evidence is mixed. In one study, doctors gave 247 people with MASH and without diabetes a daily pill with either pioglitazone, vitamin E, or a placebo. After 22 months, people who took pioglitazone did not have improvements in their MASH.",
        "But other studies have shown the pioglitazone fights MASH and calms down inflammation. It also may help a little bit with liver scarring. It may be especially effective for people with type 2 diabetes.",
        "We need more research to know for sure how effective this medication is. Doctors are looking for people with type 2 diabetes and MASH to participate in a phase II clinical trial ."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "Most other MASH treatments are GLP-1 agonists, but this one is a PPAR-γ agonist. That means it works on a different chemical in the body.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "You take 30-45 mg per day as a tablet.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Pioglitazone has been studied in phase III and IV clinical trials, but it hasn’t been approved by the FDA to treat MASH.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "The evidence is mixed. In one study, doctors gave 247 people with MASH and without diabetes a daily pill with either pioglitazone, vitamin E, or a placebo. After 22 months, people who took pioglitazone did not have improvements in their MASH.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "But other studies have shown the pioglitazone fights MASH and calms down inflammation. It also may help a little bit with liver scarring. It may be especially effective for people with type 2 diabetes.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "We need more research to know for sure how effective this medication is. Doctors are looking for people with type 2 diabetes and MASH to participate in a phase II clinical trial .",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "Vitamin E",
      "content": [
        "This vitamin is a type of antioxidant. It destroys free radicals, which are chemicals that can lead to cancer and other diseases.",
        "It gets rid of harmful free radicals, which can lead to inflammation.",
        "Vitamin E is an antioxidant you can buy over the counter.",
        "You can take it as a daily tablet.",
        "Vitamin E has been in a couple of major studies, but it hasn’t been approved by the FDA to treat MASH.",
        "In a phase III study, doctors gave people a pill with pioglitazone, vitamin E, or a placebo. Almost two years later, about 43% of people who took vitamin E had improvements in MASH but not scarring.",
        "Doctors want to study the long-term effects of vitamin E, as some fear it could increase the risk of prostate cancer and stroke. It is not recommended for people with diabetes or advanced cirrhosis."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "This vitamin is a type of antioxidant. It destroys free radicals, which are chemicals that can lead to cancer and other diseases.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "It gets rid of harmful free radicals, which can lead to inflammation.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Vitamin E is an antioxidant you can buy over the counter.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "You can take it as a daily tablet.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Vitamin E has been in a couple of major studies, but it hasn’t been approved by the FDA to treat MASH.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "In a phase III study, doctors gave people a pill with pioglitazone, vitamin E, or a placebo. Almost two years later, about 43% of people who took vitamin E had improvements in MASH but not scarring.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Doctors want to study the long-term effects of vitamin E, as some fear it could increase the risk of prostate cancer and stroke. It is not recommended for people with diabetes or advanced cirrhosis.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "Clinical Trials for MASH Medications",
      "content": [
        "If you’re interested in trying a new medication for MASH, talk with your doctor. They can help you choose the best drug for you. If that drug is still being researched, they can help you join a clinical trial that you may qualify for. You can also find a list of clinical trials at clinicaltrials.gov .",
        "If you find a study that looks like a good fit, you can meet with someone from the research team to find out more and confirm that you meet the enrollment criteria. You’ll need to sign a consent form. You may get a treatment that’s not yet available to the public, and any travel expenses may be paid. There are strict guidelines in place to make sure that your treatment as part of the study is safe. You can stop your involvement at any time for any reason. Taking part in a study is a way to not only be actively involved in your care but also to potentially help find a medication that will help others with the same condition."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "If you’re interested in trying a new medication for MASH, talk with your doctor. They can help you choose the best drug for you. If that drug is still being researched, they can help you join a clinical trial that you may qualify for. You can also find a list of clinical trials at clinicaltrials.gov .",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "If you find a study that looks like a good fit, you can meet with someone from the research team to find out more and confirm that you meet the enrollment criteria. You’ll need to sign a consent form. You may get a treatment that’s not yet available to the public, and any travel expenses may be paid. There are strict guidelines in place to make sure that your treatment as part of the study is safe. You can stop your involvement at any time for any reason. Taking part in a study is a way to not only be actively involved in your care but also to potentially help find a medication that will help others with the same condition.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "Vitamin E",
      "content": [
        "This vitamin is a type of antioxidant. It destroys free radicals, which are chemicals that can lead to cancer and other diseases.",
        "It gets rid of harmful free radicals, which can lead to inflammation.",
        "Vitamin E is an antioxidant you can buy over the counter.",
        "You can take it as a daily tablet.",
        "Vitamin E has been in a couple of major studies, but it hasn’t been approved by the FDA to treat MASH.",
        "In a phase III study, doctors gave people a pill with pioglitazone, vitamin E, or a placebo. Almost two years later, about 43% of people who took vitamin E had improvements in MASH but not scarring.",
        "Doctors want to study the long-term effects of vitamin E, as some fear it could increase the risk of prostate cancer and stroke. It is not recommended for people with diabetes or advanced cirrhosis."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "This vitamin is a type of antioxidant. It destroys free radicals, which are chemicals that can lead to cancer and other diseases.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "It gets rid of harmful free radicals, which can lead to inflammation.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Vitamin E is an antioxidant you can buy over the counter.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "You can take it as a daily tablet.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Vitamin E has been in a couple of major studies, but it hasn’t been approved by the FDA to treat MASH.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "In a phase III study, doctors gave people a pill with pioglitazone, vitamin E, or a placebo. Almost two years later, about 43% of people who took vitamin E had improvements in MASH but not scarring.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Doctors want to study the long-term effects of vitamin E, as some fear it could increase the risk of prostate cancer and stroke. It is not recommended for people with diabetes or advanced cirrhosis.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "Clinical Trials for MASH Medications",
      "content": [
        "If you’re interested in trying a new medication for MASH, talk with your doctor. They can help you choose the best drug for you. If that drug is still being researched, they can help you join a clinical trial that you may qualify for. You can also find a list of clinical trials at clinicaltrials.gov .",
        "If you find a study that looks like a good fit, you can meet with someone from the research team to find out more and confirm that you meet the enrollment criteria. You’ll need to sign a consent form. You may get a treatment that’s not yet available to the public, and any travel expenses may be paid. There are strict guidelines in place to make sure that your treatment as part of the study is safe. You can stop your involvement at any time for any reason. Taking part in a study is a way to not only be actively involved in your care but also to potentially help find a medication that will help others with the same condition."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "If you’re interested in trying a new medication for MASH, talk with your doctor. They can help you choose the best drug for you. If that drug is still being researched, they can help you join a clinical trial that you may qualify for. You can also find a list of clinical trials at clinicaltrials.gov .",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "If you find a study that looks like a good fit, you can meet with someone from the research team to find out more and confirm that you meet the enrollment criteria. You’ll need to sign a consent form. You may get a treatment that’s not yet available to the public, and any travel expenses may be paid. There are strict guidelines in place to make sure that your treatment as part of the study is safe. You can stop your involvement at any time for any reason. Taking part in a study is a way to not only be actively involved in your care but also to potentially help find a medication that will help others with the same condition.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "Beyond Medications for MASH",
      "content": [
        "Su adds that it’s important to remember the basics: diet and exercise. “One thing to keep in mind is that while we are so excited about finally having effective therapy for the treatment of MASH, lifestyle modifications like diet and exercise remain very important,” she says.",
        "Advances in medications have made the treatment of MASH more effective than ever before. But lifestyle changes are key: The main ways to treat MASH are still a healthy diet and exercise. This includes actions such as eating the Mediterranean diet, doing cardiovascular exercises such as jogging and swimming, and avoiding alcohol.",
        "If you have obesity and advanced liver disease, bariatric (weight loss) surgery may be an option. This kind of surgery will not only help you lose weight but also can help improve or reverse liver damage. It also lowers your chances of cirrhosis, liver cancer, and needing a liver transplant."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "Su adds that it’s important to remember the basics: diet and exercise. “One thing to keep in mind is that while we are so excited about finally having effective therapy for the treatment of MASH, lifestyle modifications like diet and exercise remain very important,” she says.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Advances in medications have made the treatment of MASH more effective than ever before. But lifestyle changes are key: The main ways to treat MASH are still a healthy diet and exercise. This includes actions such as eating the Mediterranean diet, doing cardiovascular exercises such as jogging and swimming, and avoiding alcohol.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "If you have obesity and advanced liver disease, bariatric (weight loss) surgery may be an option. This kind of surgery will not only help you lose weight but also can help improve or reverse liver damage. It also lowers your chances of cirrhosis, liver cancer, and needing a liver transplant.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "Beyond Medications for MASH",
      "content": [
        "Su adds that it’s important to remember the basics: diet and exercise. “One thing to keep in mind is that while we are so excited about finally having effective therapy for the treatment of MASH, lifestyle modifications like diet and exercise remain very important,” she says.",
        "Advances in medications have made the treatment of MASH more effective than ever before. But lifestyle changes are key: The main ways to treat MASH are still a healthy diet and exercise. This includes actions such as eating the Mediterranean diet, doing cardiovascular exercises such as jogging and swimming, and avoiding alcohol.",
        "If you have obesity and advanced liver disease, bariatric (weight loss) surgery may be an option. This kind of surgery will not only help you lose weight but also can help improve or reverse liver damage. It also lowers your chances of cirrhosis, liver cancer, and needing a liver transplant."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "Su adds that it’s important to remember the basics: diet and exercise. “One thing to keep in mind is that while we are so excited about finally having effective therapy for the treatment of MASH, lifestyle modifications like diet and exercise remain very important,” she says.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Advances in medications have made the treatment of MASH more effective than ever before. But lifestyle changes are key: The main ways to treat MASH are still a healthy diet and exercise. This includes actions such as eating the Mediterranean diet, doing cardiovascular exercises such as jogging and swimming, and avoiding alcohol.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "If you have obesity and advanced liver disease, bariatric (weight loss) surgery may be an option. This kind of surgery will not only help you lose weight but also can help improve or reverse liver damage. It also lowers your chances of cirrhosis, liver cancer, and needing a liver transplant.",
          "associated_bullets": null
        }
      ]
    }
  ],
  "pdfs": [],
  "images": [
    "https://img.lb.wbmdstatic.com/vim/live/webmd/consumer_assets/site_images/article_thumbnails/features/_2025/05_2025/whats-new-in-cancer-treatments-features/1800x1200-whats-new-in-cancer-treatments-features.jpg",
    "https://img.wbmdstatic.com/vim/live/webmd/consumer_assets/site_images/logos/webmd/web/webmd_logo_white.svg",
    "https://img.lb.wbmdstatic.com/vim/live/webmd/consumer_assets/site_images/articles/biographies/382x382_deanna_altomara_headshot.jpg?resize=51px:51px&output-quality=75",
    "https://img.lb.wbmdstatic.com/vim/live/webmd/consumer_assets/site_images/articles/biographies/ratini_melinda_382x382.jpg?resize=51px:51px&output-quality=75",
    "https://img.lb.wbmdstatic.com/vim/live/webmd/consumer_assets/site_images/article_thumbnails/other/fatty-liver-disease-health-center-toc-other/More_On_Fatty_Liver.png?resize=300px:*&output-quality=75",
    "https://img.lb.wbmdstatic.com/vim/live/webmd/consumer_assets/site_images/article_thumbnails/other/fatty-liver-disease-health-center-toc-other/SR_FattyLiver.png?resize=500px:*&output-quality=75",
    "https://privacy-policy.truste.com/privacy-seal/seal?rid=07326333-3522-463d-81bf-f00fd7171fff",
    "https://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/layout/shared/tag-registered.png?resize=*:60px",
    "https://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/oncology/1/footer-images/ad-choice.png",
    "https://img.wbmdstatic.com/vim/live/webmd/consumer_assets/site_images/oncology/1/images/webmd-logo-white.svg",
    "https://sb.scorecardresearch.com/p?c1=2&c2=6035829&cv=3.6&cj=1"
  ],
  "related_links": [],
  "sources": [
    "Photo credit: E+/Getty Images",
    "Grace Su, MD, FAASLD, president, American Association for the Study of Liver Diseases, Alexandria, VA.",
    "Yale Medicine: “ MASH (Formerly NASH): Understanding This Form of Fatty Liver Disease .”",
    "Diabetes Care : “ Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association .”",
    "BMC Gastroenterology : “ The Role of Ursodeoxycholic Acid in Non-Alcoholic Steatohepatitis: A Systematic Review .”",
    "Cleveland Clinic: “ Liraglutide Injection (Diabetes) ,” “ Metabolic Dysfunction-Associated Steatohepatitis (MASH), ” “ Clinical Trial (Clinical Study) .”",
    "Clinical Gastroenterology and Hepatology : “ The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis .”",
    "ClinicalTrials.gov : “ A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) ,” “ University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial) ,” “ Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS) (PIVENS) ,” “ Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE) .”",
    "International Journal of Molecular Sciences : “ Pharmacological Treatment of MASLD: Contemporary Treatment and Future Perspectives .”",
    "JAMA Internal Medicine : “ Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity .”",
    "The Lancet : “ Liraglutide Safety and Efficacy in Patients with Non-Alcoholic Steatohepatitis (Lean): A Multicentre, Double-Blind, Randomised, Placebo-Controlled Phase 2 Study .”",
    "Mayo Clinic: “ Vitamin E .”",
    "The New England Journal of Medicine : ” Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis ,” “ Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis .”",
    "Rezdiffra: “ Frequently Asked Questions .”",
    "FDA: “ FDA Approves First Treatment for Patients with Liver Scarring Due to Fatty Liver Disease ,” “ FDA Approves Treatment for Serious Liver Disease Known as ‘MASH.’ ”",
    "Gastro Hep Advances : “ Farnesoid X Receptor Agonists: A Promising Therapeutic Strategy for Gastrointestinal Diseases .”",
    "Journal of Hepatology : “ FXR Agonists in NASH Treatment .”",
    "Medicine : “ The effect and safety of obeticholic acid for patients with nonalcoholic steatohepatitis: A systematic review and meta-analysis of randomized controlled trials .”"
  ],
  "meta_description": "Get to know the newest advances in treatment for MASH and what the future of treatment looks like for fatty liver disease.",
  "canonical_url": "https://www.webmd.com/fatty-liver-disease/cm/mash-treatments-latest-treatments",
  "tags": [
    "Health Topics",
    "WebMD"
  ],
  "scrape_timestamp_utc": "2026-01-23T03:40:12.954626Z"
}